Stratifying the NHS Diabetic Eye Screening Programme: into the unknown?

被引：3

作者：

Sampson, C. J. ^{[1
]}

James, M. ^{[1
]}

Broadbent, D. M. ^{[2
,3
]}

Harding, S. P. ^{[2
,3
]}

机构：

[1] Univ Nottingham, Sch Med, Div Rehabil & Ageing, Nottingham, England

[2] Royal Liverpool Univ Hosp, St Pauls Eye Unit, Liverpool, Merseyside, England

[3] Univ Liverpool, Inst Ageing & Chron Dis, Dept Eye & Vis Sci, Liverpool, Merseyside, England

来源：

DIABETIC MEDICINE | 2016年 / 33卷 / 12期

关键词：

COST-EFFECTIVENESS ANALYSIS; RETINOPATHY; INTERVALS;

D O I：

10.1111/dme.13192

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1612 / 1614

页数：3

共 10 条

[1] Adopting 3-Year Screening Intervals for Sight-Threatening Retinal Vascular Lesions in Type 2 Diabetic Subjects Without Retinopathy [J].

Agardh, Elisabet ;

Tababat-Khani, Poya .

DIABETES CARE, 2011, 34 (06) :1318-1319

[2] Is risk stratification ever the same as 'profiling'? [J].

Braithwaite, R. Scott ;

Stevens, Elizabeth R. ;

Caplan, Arthur .

JOURNAL OF MEDICAL ETHICS, 2016, 42 (05) :325-329

[3] Cost effectiveness analysis of screening for sight threatening diabetic eye disease [J].

James, M ;

Turner, DA ;

Broadbent, DM ;

Vora, J ;

Harding, SP .

BRITISH MEDICAL JOURNAL, 2000, 320 (7250) :1627-1631

[4] Progression of Diabetes Retinal Status Within Community Screening Programs and Potential Implications for Screening Intervals [J].

Leese, Graham P. ;

Stratton, Irene M. ;

Land, Martin ;

Bachmann, Max O. ;

Jones, Colin ;

Scanlon, Peter ;

Looker, Helen C. ;

Ferguson, Brian .

DIABETES CARE, 2015, 38 (03) :488-494

[5] Development of a cost-effectiveness model for optimisation of the screening interval in diabetic retinopathy screening [J].

Scanlon, Peter H. ;

Aldington, Stephen J. ;

Leal, Jose ;

Luengo-Fernandez, Ramon ;

Oke, Jason ;

Sivaprasad, Sobha ;

Gazis, Anastasios ;

Stratton, Irene M. .

HEALTH TECHNOLOGY ASSESSMENT, 2015, 19 (74) :1-+

[6] Subgroups and heterogeneity in cost-effectiveness analysis [J].

Sculpher, Mark .

PHARMACOECONOMICS, 2008, 26 (09) :799-806

[7] Extending the diabetic retinopathy screening interval beyond 1 year: systematic review [J].

Taylor-Phillips, Sian ;

Mistry, Hema ;

Leslie, Rachael ;

Todkill, Dan ;

Tsertsvadze, Alexander ;

Connock, Martin ;

Clarke, Aileen .

BRITISH JOURNAL OF OPHTHALMOLOGY, 2016, 100 (01) :105-114

[8]

UK National Screening Committee (UK NSC), 2016, UK NSC REC DIAB RET

[9] Diabetic retinopathy screening: perspectives of people with diabetes, screening intervals and costs of attending screening [J].

Yeo, S. T. ;

Edwards, R. T. ;

Luzio, S. D. ;

Charles, J. M. ;

Thomas, R. L. ;

Peters, J. M. ;

Owens, D. R. .

DIABETIC MEDICINE, 2012, 29 (07) :878-885

[10] Incidence of sight-threatening retinopathy in patients with type 2 diabetes in the Liverpool Diabetic Eye Study: a cohort study [J].

Younis, N ;

Broadbent, DM ;

Vora, JP ;

Harding, SP .

LANCET, 2003, 361 (9353) :195-200

← 1 →